Biobanking Clinical Trials

• Understanding Chronic Lymphocytic Leukemia
• ​Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies

Clinical Trials involving Novel Treatments of CLL 

• ​Acalabrutinib, Obinutuzumab, and Venetoclax for initial therapy of CLL (AVO)
• Duvelisib and Venetoclax for Relapsed or Refractory CLL or SLL
• ​A Study of Ibrutinib and Obinutuzumab in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
• A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL
• A Study comparing BGB-3111 with Bendamustine with Rituxumab in Patients with previously Untreated CLL or SLL
• Safety and Efficacy of KTE-C19 in Adults with Relapsed/Refractory Chronic Lymphocytic Leukemia (ZUMA-8)
• Pyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma